5α-Reductase Inhibitors: Progress and Therapeutic Potential

    January 2001 in “ Advances in protein chemistry
    John D. McConnell, Elizabeth Stoner
    Image of study
    TLDR 5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.
    This chapter reviewed the progress in developing and using 5α-reductase inhibitors to treat disorders mediated by dihydrotestosterone (DHT), a key androgen. It highlighted the significant advancements in understanding androgen biology through these inhibitors. The chapter also discussed the potential of new 5α-reductase inhibitors in development to further elucidate the role of DHT and 5α-reductase in androgen biology and their therapeutic potential for androgenic disorders. The importance of DHT as a potent androgen, distinct from testosterone, was underscored by studies from 1974 on a rare inborn disorder caused by 5α-reductase deficiency, which affects male sexual differentiation.
    Discuss this study in the Community →

    Research cited in this study

    37 / 37 results

    Related Community Posts Join

    6 / 90 results

    Similar Research

    5 / 1000+ results
      Clinical Use of 5α-Reductase Inhibitors

      research Clinical Use of 5α-Reductase Inhibitors

      3 citations, January 2001 in “Cambridge University Press eBooks”
      Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.
      Male Androgenetic Alopecia

      research Male Androgenetic Alopecia

      54 citations, July 2002 in “Clinical and Experimental Dermatology”
      DHT, a testosterone byproduct, causes male pattern baldness.
      Hormonal Therapy for Acne

      research Hormonal Therapy for Acne

      1 citations, November 1996 in “Journal of Cutaneous Medicine and Surgery”
      Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.